Literature DB >> 16356849

The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA.

Lan Chun Tu1, Chien-Shu Chen, I-Ching Hsiao, Ji-Wang Chern, Chi-Hung Lin, Ya-Ching Shen, Sheau Farn Yeh.   

Abstract

Mana-Hox, an analog of beta-carbolines with anticancer activity, induces aberrant mitosis and delays mitotic exit. However, the cellular target is not known. In this study, we visualized the intracellular localization of Mana-Hox. Mana-Hox rapidly penetrated into cells (within 1 min) and concentrated on disorganized metaphase chromosomes after 13 hr of exposure. We demonstrated that Mana-Hox is a noncovalent DNA binder that can interact with DNA through intercalation and/or through minor groove binding. Furthermore, Mana-Hox also inhibits topoisomerase II relaxation activity in vitro, suggesting that Mana-Hox could perturb mitotic chromosome decatenation. Overall, Mana-Hox binding to DNA plays a critical role in the induction of aberrant mitosis and contributes to its anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356849     DOI: 10.1016/j.chembiol.2005.09.014

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  7 in total

1.  A spectroscopic study of the interaction of the fluorescent beta-carboline-3-carboxylic acid N-methylamide with DNA constituents: nucleobases, nucleosides and nucleotides.

Authors:  Iñigo X García-Zubiri; Hugh D Burrows; Joao S Seixas de Melo; María Monteserín; Antonio Arroyo; María J Tapia
Journal:  J Fluoresc       Date:  2008-05-11       Impact factor: 2.217

2.  Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.

Authors:  Che-Jen Hsiao; Yunn-Fang Ho; John T-A Hsu; Wei-Ling Chang; Yi-Cheng Chen; Ya-Ching Shen; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

3.  DNA-binding studies of the natural β-carboline eudistomin U.

Authors:  Jennifer M Giulietti; Patrick M Tate; Ang Cai; Bongsup Cho; Seann P Mulcahy
Journal:  Bioorg Med Chem Lett       Date:  2016-08-18       Impact factor: 2.823

4.  Synthesis, characterization, and DNA binding, photocleavage, cytotoxicity, cellular uptake, apoptosis, and on-off light switching studies of Ru(II) mixed-ligand complexes containing 7-fluorodipyrido[3,2-a:2',3'-c]phenazine.

Authors:  Nancherla Deepika; Yata Praveen Kumar; Chittimalli Shobha Devi; Putta Venkat Reddy; Avudoddi Srishailam; Sirasani Satyanarayana
Journal:  J Biol Inorg Chem       Date:  2013-07-12       Impact factor: 3.358

5.  Synthesis of 1-substituted carbazolyl-1,2,3,4-tetrahydro- and carbazolyl-3,4-dihydro-β-carboline analogs as potential antitumor agents.

Authors:  Ya-Ching Shen; Yao-To Chang; Chun-Ling Lin; Chia-Ching Liaw; Yao Haur Kuo; Lan-Chun Tu; Sheau Farn Yeh; Ji-Wang Chern
Journal:  Mar Drugs       Date:  2011-02-10       Impact factor: 6.085

6.  Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.

Authors:  Li-Juan Deng; Qun-Long Peng; Long-Hai Wang; Jun Xu; Jun-Shan Liu; Ying-Jie Li; Zhen-Jian Zhuo; Liang-Liang Bai; Li-Ping Hu; Wei-Min Chen; Wen-Cai Ye; Dong-Mei Zhang
Journal:  Oncotarget       Date:  2015-10-27

7.  Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.

Authors:  Shan Li; Yuji Wang; Feng Wang; Yaonan Wang; Xiaoyi Zhang; Ming Zhao; Qiqi Feng; Jianhui Wu; Shurui Zhao; Wei Wu; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2015-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.